OVID
Companies
NASDAQ
Ovid Therapeutics Inc.
Health Care
$0.29
-$0.62 (-65.95%)
Price Chart
Overview
About OVID
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Market Cap
$210.0M
Volume
179.4K
Avg. Volume
107.5K
P/E Ratio
-0.65384614
Dividend Yield
0.00%
Employees
47.0
Company Information
Latest News for OVID
Risk & Correlation Analysis
Market Correlation
1.46
High Correlation
Volatility
High (0.85)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OVID shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$210.0M
Volume179.4K
P/E Ratio-0.65
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 11, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025